Device Trial Radar · NCT03725306
Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss
Last checked: Nov 20, 2026Latest source record: Nov 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
200
Planned (sponsor's estimate)
Start
Jan 1, 2019
Primary completion
Sep 1, 2022
Study completion Dec 1, 2022
Sponsor
- Lead sponsor
- LiNA MedicalNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Syntactx; West Virginia University, Pathology Laboratory for Translational Medicine; Infinite Clinical Research, S.A. de C.V.
- First posted
- Oct 31, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 25 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the safety and effectiveness of the endometrial ablation device Librata in reducing menstrual blood loss at 12 months post-treatment when used in pre-menopausal women with menorrhagia due to benign causes for whom childbearing is complete.
Conditions
- Menorrhagia
- Heavy Menstrual Bleeding
Interventions
LibrataDevice
Hyperthermic endomyometrial treatment via Librata catheter and balloon device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Menstrual BleedingTime frame: 12 months post-treatment
1 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.